Missing Avatar

Enzo Lalli

PI - Institut de Pharmacologie Moléculaire et Cellulaire CNRS View Biosketch →

Position - Company  
PI - Institut de Pharmacologie Moléculaire et Cellulaire CNRS Jan 2005 - Present
Degree - University  
Board Certificate, Hematology - Bologna University 1988 - 1991
M.D., Medicine - Bologna University 1982 - 1988
Publication Info
Identity by descent mapping of founder mutations in cancer using high-resolution tumor SNP data. Letouzé E, Sow A, Petel F, Rosati R, Figueiredo BC, Burnichon N, Gimenez-Roqueplo AP, Lalli E, de Reyniès A PLoS One. 7(5):e35897. doi: 10.1371/journal.pone.0035897. May 2, 2012. View on PubMed.
SNP Array Profiling of Childhood Adrenocortical Tumors Reveals Distinct Pathways of Tumorigenesis and Highlights Candidate Driver Genes. Letouzé E, Rosati R, Komechen H, Doghman M, Marisa L, Flück C, de Krijger RR and 6 others J Clin Endocrinol Metab. :. doi: 10.1210/jc.2012-1184. April 26, 2012. View on PubMed.
Adrenal cancer: scientific advances. Hammer GD, Fassnacht M, Lalli E Mol Cell Endocrinol. 351(1):1. doi: 10.1016/j.mce.2011.11.010. March 31, 2012. View on PubMed.
Dysregulation of microRNAs in adrenocortical tumors. Singh P, Soon PS, Feige JJ, Chabre O, Zhao JT, Cherradi N, Lalli E, Sidhu SB Mol Cell Endocrinol. 351(1):118-28. doi: 10.1016/j.mce.2011.09.041. March 31, 2012. View on PubMed.
Adrenal cancer: clinical advances. Hammer GD, Fassnacht M, Lalli E Horm Cancer. 2(6):323. doi: 10.1007/s12672-011-0092-4. December 2011. View on PubMed.
Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markers. Boulkroun S, Samson-Couterie B, Golib-Dzib JF, Amar L, Plouin PF, Sibony M, Lefebvre H and 6 others Endocrinology. 152(12):4753-63. doi: 10.1210/en.2011-1205. October 4, 2011. View on PubMed.
Genetics and genomics of childhood adrenocortical tumors. El Wakil A, Doghman M, Latre De Late P, Zambetti GP, Figueiredo BC, Lalli E Mol Cell Endocrinol. 336(1-2):169-73. doi: 10.1016/j.mce.2010.11.008. April 10, 2011. View on PubMed.
Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil. Custodio G, Taques GR, Figueiredo BC, Gugelmin ES, Oliveira Figueiredo MM, Watanabe F, Pontarolo R, Lalli E, Torres LF PLoS One. 6(3):e18015. doi: 10.1371/journal.pone.0018015. March 22, 2011. View on PubMed.
The Wnt/beta-catenin pathway in adrenocortical development and cancer. El Wakil A, Lalli E Mol Cell Endocrinol. 332(1-2):32-7. doi: 10.1016/j.mce.2010.11.014. January 30, 2011. View on PubMed.
Potent inhibitory effect of the cyclolignan picropodophyllin (PPP) on human adrenocortical carcinoma cells proliferation. Doghman M, Axelson M, Lalli E Am J Cancer Res. 1(3):356-361. January 5, 2011. View on PubMed.
Therapy of adrenocortical cancer: present and future. Maluf DF, de Oliveira BH, Lalli E Am J Cancer Res. 1(2):222-232. December 7, 2010. View on PubMed.
Adrenal cortex ontogenesis. Lalli E Best Pract Res Clin Endocrinol Metab. 24(6):853-64. doi: 10.1016/j.beem.2010.10.009. December 2010. View on PubMed.
Gonadotropin-dependent precocious puberty in a patient with X-linked adrenal hypoplasia congenita caused by a novel DAX-1 mutation. Darcan S, Goksen D, Ozen S, Ozkinay F, Durmaz B, Lalli E Horm Res Paediatr. 75(2):153-6. doi: 10.1159/000320701. October 22, 2010. View on PubMed.
Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism. Boulkroun S, Samson-Couterie B, Dzib JF, Lefebvre H, Louiset E, Amar L, Plouin PF and 5 others Hypertension. 56(5):885-92. doi: 10.1161/HYPERTENSIONAHA.110.158543. October 11, 2010. View on PubMed.
Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. Doghman M, El Wakil A, Cardinaud B, Thomas E, Wang J, Zhao W, Peralta-Del Valle MH, Figueiredo BC, Zambetti GP, Lalli E Cancer Res. 70(11):4666-75. doi: 10.1158/0008-5472.CAN-09-3970. June 1, 2010. View on PubMed.
Heterozygous TP53stop146/R72P fibroblasts from a Li-Fraumeni syndrome patient with impaired response to DNA damage. De Moura J, Kavalec FL, Doghman M, Rosati R, Custodio G, Lalli E, Cavallari GM, Santa Maria J, Figueiredo BC Int J Oncol. 36(4):983-90. April 2010. View on PubMed.
Adrenocortical development and cancer: focus on SF-1. Lalli E J Mol Endocrinol. 44(6):301-7. doi: 10.1677/JME-09-0143. March 3, 2010. View on PubMed.
Targeting DAX-1 in embryonic stem cells and cancer. Lalli E, Alonso J Expert Opin Ther Targets. 14(2):169-77. doi: 10.1517/14728220903531454. February 2010. View on PubMed.
Identification and characterization of steroidogenic factor-1 inverse agonists. Doghman M, Madoux F, Hodder P, Lalli E Methods Enzymol. 485:3-23. doi: 10.1016/B978-0-12-381296-4.00001-4. 2010. View on PubMed.
Dax-1 knockdown in mouse embryonic stem cells induces loss of pluripotency and multilineage differentiation. Khalfallah O, Rouleau M, Barbry P, Bardoni B, Lalli E Stem Cells. 27(7):1529-37. doi: 10.1002/stem.78. July 2009. View on PubMed.
Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonists. Doghman M, Cazareth J, Douguet D, Madoux F, Hodder P, Lalli E J Clin Endocrinol Metab. 94(6):2178-83. doi: 10.1210/jc.2008-2163. March 24, 2009. View on PubMed.
A matter of dosage: SF-1 in adrenocortical development and cancer. Doghman M, Lalli E Ann Endocrinol (Paris). 70(3):148-52. doi: 10.1016/j.ando.2009.02.002. March 17, 2009. View on PubMed.
E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis. Ehrlund A, Anthonisen EH, Gustafsson N, Venteclef N, Robertson Remen K, Damdimopoulos AE, Galeeva A and 5 others Mol Cell Biol. 29(8):2230-42. doi: 10.1128/MCB.00743-08. February 23, 2009. View on PubMed.
FRAXE-associated mental retardation protein (FMR2) is an RNA-binding protein with high affinity for G-quartet RNA forming structure. Bensaid M, Melko M, Bechara EG, Davidovic L, Berretta A, Catania MV, Gecz J, Lalli E, Bardoni B Nucleic Acids Res. 37(4):1269-79. doi: 10.1093/nar/gkn1058. January 9, 2009. View on PubMed.
Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells. Ye P, Nakamura Y, Lalli E, Rainey WE Endocrinology. 150(3):1303-9. doi: 10.1210/en.2008-0667. October 30, 2008. View on PubMed.
DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells. García-Aragoncillo E, Carrillo J, Lalli E, Agra N, Gómez-López G, Pestaña A, Alonso J Oncogene. 27(46):6034-43. doi: 10.1038/onc.2008.203. October 9, 2008. View on PubMed.
High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation. Rosati R, Cerrato F, Doghman M, Pianovski MA, Parise GA, Custódio G, Zambetti GP and 4 others Cancer Genet Cytogenet. 186(1):19-24. doi: 10.1016/j.cancergencyto.2008.05.010. October 2008. View on PubMed.
The T cell factor/beta-catenin antagonist PKF115-584 inhibits proliferation of adrenocortical carcinoma cells. Doghman M, Cazareth J, Lalli E J Clin Endocrinol Metab. 93(8):3222-5. doi: 10.1210/jc.2008-0247. June 10, 2008. View on PubMed.
Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis. Heitzmann D, Derand R, Jungbauer S, Bandulik S, Sterner C, Schweda F, El Wakil A and 13 others EMBO J. 27(1):179-87. doi: 10.1038/sj.emboj.7601934. January 9, 2008. View on PubMed.
Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Doghman M, Karpova T, Rodrigues GA, Arhatte M, De Moura J, Cavalli LR, Virolle V and 5 others Mol Endocrinol. 21(12):2968-87. doi: 10.1210/me.2007-0120. August 30, 2007. View on PubMed.
Regulation of human MC2-R gene expression by CREB, CREM, and ICER in the adrenocortical cell line Y1. Zwermann O, Braun AC, Lalli E, Sassone-Corsi P, Beuschlein F, Reincke M Horm Metab Res. 39(8):560-6. doi: 10.1055/s-2007-985141. August 2007. View on PubMed.
Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors. Doghman M, Arhatte M, Thibout H, Rodrigues G, De Moura J, Grosso S, West AN and 8 others J Clin Endocrinol Metab. 92(8):3253-60. doi: 10.1210/jc.2007-0342. June 12, 2007. View on PubMed.
Gene expression profiling of childhood adrenocortical tumors. West AN, Neale GA, Pounds S, Figueredo BC, Rodriguez Galindo C, Pianovski MA, Oliveira Filho AG and 4 others Cancer Res. 67(2):600-8. doi: 10.1158/0008-5472.CAN-06-3767. January 15, 2007. View on PubMed.
Fragile X related protein 1 isoforms differentially modulate the affinity of fragile X mental retardation protein for G-quartet RNA structure. Bechara E, Davidovic L, Melko M, Bensaid M, Tremblay S, Grosgeorge J, Khandjian EW, Lalli E, Bardoni B Nucleic Acids Res. 35(1):299-306. doi: 10.1093/nar/gkl1021. December 14, 2006. View on PubMed.
Partial defects in transcriptional activity of two novel DAX-1 mutations in childhood-onset adrenal hypoplasia congenita. Laissue P, Copelli S, Bergada I, Bergada C, Barrio G, Karaboga S, Wurtz JM, Fellous M, Lalli E, Veitia RA Clin Endocrinol (Oxf). 65(5):681-6. doi: 10.1111/j.1365-2265.2006.02649.x. November 2006. View on PubMed.
Transcriptional regulation of the glucose-6-phosphatase gene by cAMP/vasoactive intestinal peptide in the intestine. Role of HNF4alpha, CREM, HNF1alpha, and C/EBPalpha. Gautier-Stein A, Zitoun C, Lalli E, Mithieux G, Rajas F J Biol Chem. 281(42):31268-78. doi: 10.1074/jbc.M603258200. October 20, 2006. View on PubMed.
SF-1 overexpression in childhood adrenocortical tumours. Pianovski MA, Cavalli LR, Figueiredo BC, Santos SC, Doghman M, Ribeiro RC, Oliveira AG and 5 others Eur J Cancer. 42(8):1040-3. doi: 10.1016/j.ejca.2006.01.022. March 29, 2006. View on PubMed.
The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors. Mendiola M, Carrillo J, García E, Lalli E, Hernández T, de Alava E, Tirode F and 5 others Int J Cancer. 118(6):1381-9. doi: 10.1002/ijc.21578. March 15, 2006. View on PubMed.
Specific immunoassays for placental alkaline phosphatase as a tumor marker. Stinghen ST, Moura JF, Zancanella P, Rodrigues GA, Pianovski MA, Lalli E, Arnold DL and 4 others J Biomed Biotechnol. 2006(5):56087. doi: 10.1155/JBB/2006/56087. 2006. View on PubMed.
Heat shock affects trafficking of DAX-1 by inducing its rapid and reversible cytoplasmic localization. Lehmann SG, Sassone-Corsi P, Lalli E Endocrine. 28(2):137-44. doi: 10.1385/ENDO:28:2:137. November 2005. View on PubMed.
Combinations of genetic changes in the human cAMP-responsive element modulator gene: a clue towards understanding some forms of male infertility? Vouk K, Hudler P, Strmsnik L, Fink M, Majdic G, Zorn B, Lalli E and 4 others Mol Hum Reprod. 11(8):567-74. doi: 10.1093/molehr/gah209. September 2, 2005. View on PubMed.
Regulation of adrenocortical cardiotonic steroid production by dopamine and PKA signaling. Dmitrieva RI, Lalli E, Doris PA Front Biosci. 10:2489-95. September 1, 2005. View on PubMed.
Extracellular matrix and hormones modulate DAX-1 localization in the human fetal adrenal gland. Battista MC, Otis M, Côté M, Laforest A, Peter M, Lalli E, Gallo-Payet N J Clin Endocrinol Metab. 90(9):5426-31. doi: 10.1210/jc.2005-0666. June 14, 2005. View on PubMed.
Clinical and molecular evidence for DAX-1 inhibition of steroidogenic factor-1-dependent ACTH receptor gene expression. Zwermann O, Beuschlein F, Lalli E, Klink A, Sassone-Corsi P, Reincke M Eur J Endocrinol. 152(5):769-76. doi: 10.1530/eje.1.01908. May 2005. View on PubMed.
Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors. Figueiredo BC, Cavalli LR, Pianovski MA, Lalli E, Sandrini R, Ribeiro RC, Zambetti G, DeLacerda L, Rodrigues GA, Haddad BR J Clin Endocrinol Metab. 90(2):615-9. doi: 10.1210/jc.2004-0942. November 16, 2004. View on PubMed.
NUFIP1 (nuclear FMRP interacting protein 1) is a nucleocytoplasmic shuttling protein associated with active synaptoneurosomes. Bardoni B, Willemsen R, Weiler IJ, Schenck A, Severijnen LA, Hindelang C, Lalli E, Mandel JL Exp Cell Res. 289(1):95-107. September 10, 2003. View on PubMed.
Transcriptional regulation of the mouse steroidogenic acute regulatory protein gene by the cAMP response-element binding protein and steroidogenic factor 1. Manna PR, Eubank DW, Lalli E, Sassone-Corsi P, Stocco DM J Mol Endocrinol. 30(3):381-97. June 2003. View on PubMed.
DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Lalli E, Sassone-Corsi P Mol Endocrinol. 17(8):1445-53. doi: 10.1210/me.2003-0159. May 29, 2003. View on PubMed.
Structure-function analysis reveals the molecular determinants of the impaired biological function of DAX-1 mutants in AHC patients. Lehmann SG, Wurtz JM, Renaud JP, Sassone-Corsi P, Lalli E Hum Mol Genet. 12(9):1063-72. May 1, 2003. View on PubMed.
Sexy splicing: regulatory interplays governing sex determination from Drosophila to mammals. Lalli E, Ohe K, Latorre E, Bianchi ME, Sassone-Corsi P J Cell Sci. 116(Pt 3):441-5. February 1, 2003. View on PubMed.
Regulation of niemann-pick c1 gene expression by the 3'5'-cyclic adenosine monophosphate pathway in steroidogenic cells. Gévry NY, Lalli E, Sassone-Corsi P, Murphy BD Mol Endocrinol. 17(4):704-15. doi: 10.1210/me.2002-0093. January 16, 2003. View on PubMed.
X-linked adrenal hypoplasia congenita is caused by abnormal nuclear localization of the DAX-1 protein. Lehmann SG, Lalli E, Sassone-Corsi P Proc Natl Acad Sci U S A. 99(12):8225-30. doi: 10.1073/pnas.122044099. June 11, 2002. View on PubMed.
A direct role of SRY and SOX proteins in pre-mRNA splicing. Ohe K, Lalli E, Sassone-Corsi P Proc Natl Acad Sci U S A. 99(3):1146-51. doi: 10.1073/pnas.022645899. February 5, 2002. View on PubMed.
Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family. Manna PR, Dyson MT, Eubank DW, Clark BJ, Lalli E, Sassone-Corsi P, Zeleznik AJ, Stocco DM Mol Endocrinol. 16(1):184-99. doi: 10.1210/mend.16.1.0759. January 2002. View on PubMed.
Heat shock interferes with steroidogenesis by reducing transcription of the steroidogenic acute regulatory protein gene. Murphy BD, Lalli E, Walsh LP, Liu Z, Soh J, Stocco DM, Sassone-Corsi P Mol Endocrinol. 15(8):1255-63. doi: 10.1210/mend.15.8.0676. August 2001. View on PubMed.
SF-1 (steroidogenic factor-1), C/EBPbeta (CCAAT/enhancer binding protein), and ubiquitous transcription factors NF1 (nuclear factor 1) and Sp1 (selective promoter factor 1) are required for regulation of the mouse aldose reductase-like gene (AKR1B7) expre Aigueperse C, Val P, Pacot C, Darne C, Lalli E, Sassone-Corsi P, Veyssiere G, Jean C, Martinez A Mol Endocrinol. 15(1):93-111. doi: 10.1210/mend.15.1.0577. January 2001. View on PubMed.
Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M and 5 others J Clin Endocrinol Metab. 85(10):3720-5. doi: 10.1210/jcem.85.10.6881. October 2000. View on PubMed.
Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a pathway that Is independent of cholesterol side-chain cleavage. Dmitrieva RI, Bagrov AY, Lalli E, Sassone-Corsi P, Stocco DM, Doris PA Hypertension. 36(3):442-8. September 2000. View on PubMed.
Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA. Lalli E, Ohe K, Hindelang C, Sassone-Corsi P Mol Cell Biol. 20(13):4910-21. July 2000. View on PubMed.
DAX-1 blocks steroid production at multiple levels. Lalli E, Melner MH, Stocco DM, Sassone-Corsi P Endocrinology. 139(10):4237-43. doi: 10.1210/endo.139.10.6217. October 1998. View on PubMed.
DAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesis. Reincke M, Beuschlein F, Lalli E, Arlt W, Vay S, Sassone-Corsi P, Allolio B J Clin Endocrinol Metab. 83(7):2597-600. doi: 10.1210/jcem.83.7.5095. July 1998. View on PubMed.
A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. Lalli E, Bardoni B, Zazopoulos E, Wurtz JM, Strom TM, Moras D, Sassone-Corsi P Mol Endocrinol. 11(13):1950-60. doi: 10.1210/mend.11.13.0038. December 1997. View on PubMed.
DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Zazopoulos E, Lalli E, Stocco DM, Sassone-Corsi P Nature. 390(6657):311-5. doi: 10.1038/36899. November 20, 1997. View on PubMed.
Coupling transcription to signaling pathways: cAMP and nuclear factor cAMP-responsive element modulator. Monaco L, Lamas M, Tamai K, Lalli E, Zazopoulos E, Penna L, Nantel F, Foulkes NS, Mazzucchelli C, Sassone-Corsi P Adv Second Messenger Phosphoprotein Res. 31:63-74. 1997. View on PubMed.
Hormonal and developmental regulation of DAX-1 expression in Sertoli cells. Tamai KT, Monaco L, Alastalo TP, Lalli E, Parvinen M, Sassone-Corsi P Mol Endocrinol. 10(12):1561-9. doi: 10.1210/mend.10.12.8961266. December 1996. View on PubMed.
Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development. Ikeda Y, Swain A, Weber TJ, Hentges KE, Zanaria E, Lalli E, Tamai KT and 4 others Mol Endocrinol. 10(10):1261-72. doi: 10.1210/mend.10.10.9121493. October 1996. View on PubMed.
DNA ploidy analysis of squamous cell carcinomas of the oral and maxillofacial region: clinical and pathologic correlations. Melchiorri C, Cattini L, Lalli E, Campobassi A, Marchetti C, Facchini A Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 82(3):308-14. September 1996. View on PubMed.
CREM: a master-switch in the transcriptional response to cAMP. Lamas M, Monaco L, Zazopoulos E, Lalli E, Tamai K, Penna L, Mazzucchelli C, Nantel F, Foulkes NS, Sassone-Corsi P Philos Trans R Soc Lond B Biol Sci. 351(1339):561-7. doi: 10.1098/rstb.1996.0055. April 29, 1996. View on PubMed.
The nuclear response to cAMP: role of transcription factor CREM. Lalli E, Lee JS, Lamas M, Tamai K, Zazopoulos E, Nantel F, Penna L, Foulkes NS, Sassone-Corsi P Philos Trans R Soc Lond B Biol Sci. 351(1336):201-9. doi: 10.1098/rstb.1996.0017. February 29, 1996. View on PubMed.
Block of T lymphocyte differentiation by activation of the cAMP-dependent signal transduction pathway. Lalli E, Sassone-Corsi P, Ceredig R EMBO J. 15(3):528-37. February 1, 1996. View on PubMed.
Rhythmic transcription and autoregulatory loops: nuclear pacemaker CREM. Lamas M, Lalli E, Foulkes NS, Sassone-Corsi P Cold Spring Harb Symp Quant Biol. 61:285-94. 1996. View on PubMed.
Thyroid-stimulating hormone (TSH)-directed induction of the CREM gene in the thyroid gland participates in the long-term desensitization of the TSH receptor. Lalli E, Sassone-Corsi P Proc Natl Acad Sci U S A. 92(21):9633-7. October 10, 1995. View on PubMed.
An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Zanaria E, Muscatelli F, Bardoni B, Strom TM, Guioli S, Guo W, Lalli E, Moser C, Walker AP, McCabe ER Nature. 372(6507):635-41. doi: 10.1038/372635a0. December 15, 1994. View on PubMed.
Synergism between gamma interferon and doxorubicin in a human MDR colon adenocarcinoma cell line. Monti F, Lalli E, Bontadini A, Szymczuk S, Pini E, Tononi A, Fattori PP, Facchini A, Ravaioli A J Chemother. 6(5):337-42. October 1994. View on PubMed.
Signal transduction and gene regulation: the nuclear response to cAMP. Lalli E, Sassone-Corsi P J Biol Chem. 269(26):17359-62. July 1, 1994. View on PubMed.
Flow cytometry and in vitro tritiated thymidine labeling in normal rectal mucosa of patients at high risk of colorectal cancer. Paganelli GM, Lalli E, Facchini A, Biasco G, Santucci R, Brandi G, Barbara L Am J Gastroenterol. 89(2):220-4. February 1994. View on PubMed.
Complexity and versatility of the transcriptional response to cAMP. Delmas V, Molina CA, Lalli E, de Groot R, Foulkes NS, Masquilier D, Sassone-Corsi P Rev Physiol Biochem Pharmacol. 124:1-28. 1994. View on PubMed.
Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Molina CA, Foulkes NS, Lalli E, Sassone-Corsi P Cell. 75(5):875-86. December 3, 1993. View on PubMed.
Nuclear response to cyclic AMP: central role of transcription factor CREM (cyclic-AMP-responsive-element modulator). Lalli E, Lee JS, Masquilier D, Schlotter F, Foulkes NS, Molina CA, Sassone-Corsi P Biochem Soc Trans. 21(4):912-7. November 1993. View on PubMed.
Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells. Lauri D, De Giovanni C, Biondelli T, Lalli E, Landuzzi L, Facchini A, Nicoletti G, Nanni P, Dejana E, Lollini PL Br J Cancer. 68(5):862-7. November 1993. View on PubMed.
In situ hybridization in suspension and flow cytometry as a tool for the study of gene expression. Lalli E, Gibellini D, Santi S, Facchini A Anal Biochem. 207(2):298-303. December 1992. View on PubMed.
Ly-6A/E gene is widely expressed among transformed nonhematopoietic cells. Autocrine modulation by interferon. Lollini PL, Landuzzi L, Nicoletti G, de Giovanni C, Giovarelli M, Lalli E, Facchini A, Nanni P Anticancer Res. 12(6B):2245-52. December 1992. View on PubMed.
Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferon. Nanni P, Landuzzi L, Nicoletti G, De Giovanni C, Giovarelli M, Lalli E, Facchini A, Lollini PL Br J Cancer. 66(3):479-82. September 1992. View on PubMed.
Serum markers of immune activation and liver allograft rejection. Lalli E, Meliconi R, Conte R, Mancini A, Uguccioni M, Stefanini GF, Gasbarrini G Dig Dis Sci. 37(7):1116-20. July 1992. View on PubMed.
Immune defects in families and patients with xeroderma pigmentosum and trichothiodystrophy. Mariani E, Facchini A, Honorati MC, Lalli E, Berardesca E, Ghetti P, Marinoni S, Nuzzo F, Astaldi Ricotti GC, Stefanini M Clin Exp Immunol. 88(3):376-82. June 1992. View on PubMed.
Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia. Uguccioni M, Meliconi R, Lalli E, Nesci S, Delfini C, Lucarelli G, Gasbarrini G, Facchini A J Clin Pathol. 45(4):348-51. April 1992. View on PubMed.
Increased serum concentrations of tumour necrosis factor in beta thalassaemia: effect of bone marrow transplantation. Meliconi R, Uguccioni M, Lalli E, Nesci S, Delfini C, Paradisi O, Lucarelli G, Gasbarrini G, Facchini A J Clin Pathol. 45(1):61-5. January 1992. View on PubMed.
Commercial serum-free media: hybridoma growth and monoclonal antibody production. Mariani E, Mariani AR, Monaco MC, Lalli E, Vitale M, Facchini A J Immunol Methods. 145(1-2):175-83. December 15, 1991. View on PubMed.
Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome? Meliconi R, Lalli E, Borzì RM, Sturani C, Galavotti V, Gunella G, Miniero R, Facchini A, Gasbarrini G Thorax. 45(7):536-40. July 1990. View on PubMed.
  • Enzo Lalli hasn't received any ratings yet...